Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation

Na Oh Yunn, Ara Koh, Seungmin Han, Jong Hun Lim, Sehoon Park, Jiyoun Lee, Eui Kim, Sung Key Jang, Per Olof Berggren, Sung Ho Ryu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Due to their high affinity and specificity, aptamers have been widely used as effective inhibitors in clinical applications. However, the ability to activate protein function through aptamer-protein interaction has not been well-elucidated. To investigate their potential as target-specific agonists, we used SELEX to generate aptamers to the insulin receptor (IR) and identified an agonistic aptamer named IR-A48 that specifically binds to IR, but not to IGF-1 receptor. Despite its capacity to stimulate IR autophosphorylation, similar to insulin, we found that IR-A48 not only binds to an allosteric site distinct from the insulin binding site, but also preferentially induces Y1150 phosphorylation in the IR kinase domain. Moreover, Y1150-biased phosphorylation induced by IR-A48 selectively activates specific signaling pathways downstream of IR. In contrast to insulin-mediated activation of IR, IR-A48 binding has little effect on theMAPK pathway and proliferation of cancer cells. Instead, AKT S473 phosphorylation is highly stimulated by IR-A48, resulting in increased glucose uptake both in vitro and in vivo. Here, we present IR-A48 as a biased agonist able to selectively induce the metabolic activity of IR through allosteric binding. Furthermore, our study also suggests that aptamers can be a promising tool for developing artificial biased agonists to targeted receptors.

Original languageEnglish (US)
Pages (from-to)7688-7701
Number of pages14
JournalNucleic Acids Research
Volume43
Issue number16
DOIs
StatePublished - Jul 16 2015
Externally publishedYes

Fingerprint

Insulin Receptor
Phosphorylation
Insulin
Allosteric Site
IGF Type 1 Receptor
Proteins
Phosphotransferases
Binding Sites
Cell Proliferation

ASJC Scopus subject areas

  • Genetics

Cite this

Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation. / Yunn, Na Oh; Koh, Ara; Han, Seungmin; Lim, Jong Hun; Park, Sehoon; Lee, Jiyoun; Kim, Eui; Jang, Sung Key; Berggren, Per Olof; Ryu, Sung Ho.

In: Nucleic Acids Research, Vol. 43, No. 16, 16.07.2015, p. 7688-7701.

Research output: Contribution to journalArticle

Yunn, NO, Koh, A, Han, S, Lim, JH, Park, S, Lee, J, Kim, E, Jang, SK, Berggren, PO & Ryu, SH 2015, 'Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation', Nucleic Acids Research, vol. 43, no. 16, pp. 7688-7701. https://doi.org/10.1093/nar/gkv767
Yunn, Na Oh ; Koh, Ara ; Han, Seungmin ; Lim, Jong Hun ; Park, Sehoon ; Lee, Jiyoun ; Kim, Eui ; Jang, Sung Key ; Berggren, Per Olof ; Ryu, Sung Ho. / Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation. In: Nucleic Acids Research. 2015 ; Vol. 43, No. 16. pp. 7688-7701.
@article{c7c6ebe7046940d4836e61e699bcac58,
title = "Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation",
abstract = "Due to their high affinity and specificity, aptamers have been widely used as effective inhibitors in clinical applications. However, the ability to activate protein function through aptamer-protein interaction has not been well-elucidated. To investigate their potential as target-specific agonists, we used SELEX to generate aptamers to the insulin receptor (IR) and identified an agonistic aptamer named IR-A48 that specifically binds to IR, but not to IGF-1 receptor. Despite its capacity to stimulate IR autophosphorylation, similar to insulin, we found that IR-A48 not only binds to an allosteric site distinct from the insulin binding site, but also preferentially induces Y1150 phosphorylation in the IR kinase domain. Moreover, Y1150-biased phosphorylation induced by IR-A48 selectively activates specific signaling pathways downstream of IR. In contrast to insulin-mediated activation of IR, IR-A48 binding has little effect on theMAPK pathway and proliferation of cancer cells. Instead, AKT S473 phosphorylation is highly stimulated by IR-A48, resulting in increased glucose uptake both in vitro and in vivo. Here, we present IR-A48 as a biased agonist able to selectively induce the metabolic activity of IR through allosteric binding. Furthermore, our study also suggests that aptamers can be a promising tool for developing artificial biased agonists to targeted receptors.",
author = "Yunn, {Na Oh} and Ara Koh and Seungmin Han and Lim, {Jong Hun} and Sehoon Park and Jiyoun Lee and Eui Kim and Jang, {Sung Key} and Berggren, {Per Olof} and Ryu, {Sung Ho}",
year = "2015",
month = "7",
day = "16",
doi = "10.1093/nar/gkv767",
language = "English (US)",
volume = "43",
pages = "7688--7701",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "16",

}

TY - JOUR

T1 - Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation

AU - Yunn, Na Oh

AU - Koh, Ara

AU - Han, Seungmin

AU - Lim, Jong Hun

AU - Park, Sehoon

AU - Lee, Jiyoun

AU - Kim, Eui

AU - Jang, Sung Key

AU - Berggren, Per Olof

AU - Ryu, Sung Ho

PY - 2015/7/16

Y1 - 2015/7/16

N2 - Due to their high affinity and specificity, aptamers have been widely used as effective inhibitors in clinical applications. However, the ability to activate protein function through aptamer-protein interaction has not been well-elucidated. To investigate their potential as target-specific agonists, we used SELEX to generate aptamers to the insulin receptor (IR) and identified an agonistic aptamer named IR-A48 that specifically binds to IR, but not to IGF-1 receptor. Despite its capacity to stimulate IR autophosphorylation, similar to insulin, we found that IR-A48 not only binds to an allosteric site distinct from the insulin binding site, but also preferentially induces Y1150 phosphorylation in the IR kinase domain. Moreover, Y1150-biased phosphorylation induced by IR-A48 selectively activates specific signaling pathways downstream of IR. In contrast to insulin-mediated activation of IR, IR-A48 binding has little effect on theMAPK pathway and proliferation of cancer cells. Instead, AKT S473 phosphorylation is highly stimulated by IR-A48, resulting in increased glucose uptake both in vitro and in vivo. Here, we present IR-A48 as a biased agonist able to selectively induce the metabolic activity of IR through allosteric binding. Furthermore, our study also suggests that aptamers can be a promising tool for developing artificial biased agonists to targeted receptors.

AB - Due to their high affinity and specificity, aptamers have been widely used as effective inhibitors in clinical applications. However, the ability to activate protein function through aptamer-protein interaction has not been well-elucidated. To investigate their potential as target-specific agonists, we used SELEX to generate aptamers to the insulin receptor (IR) and identified an agonistic aptamer named IR-A48 that specifically binds to IR, but not to IGF-1 receptor. Despite its capacity to stimulate IR autophosphorylation, similar to insulin, we found that IR-A48 not only binds to an allosteric site distinct from the insulin binding site, but also preferentially induces Y1150 phosphorylation in the IR kinase domain. Moreover, Y1150-biased phosphorylation induced by IR-A48 selectively activates specific signaling pathways downstream of IR. In contrast to insulin-mediated activation of IR, IR-A48 binding has little effect on theMAPK pathway and proliferation of cancer cells. Instead, AKT S473 phosphorylation is highly stimulated by IR-A48, resulting in increased glucose uptake both in vitro and in vivo. Here, we present IR-A48 as a biased agonist able to selectively induce the metabolic activity of IR through allosteric binding. Furthermore, our study also suggests that aptamers can be a promising tool for developing artificial biased agonists to targeted receptors.

UR - http://www.scopus.com/inward/record.url?scp=84942274883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942274883&partnerID=8YFLogxK

U2 - 10.1093/nar/gkv767

DO - 10.1093/nar/gkv767

M3 - Article

AN - SCOPUS:84942274883

VL - 43

SP - 7688

EP - 7701

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 16

ER -